Dupilumab Associated Head and Neck Dermatitis Resolves Temporarily with Itraconazole therapy, and Rapidly with Transition to Upadacitinib, with Malassezia-Specific IgE Levels Mirroring Clinical Response

Published: 12 May 2022| Version 1 | DOI: 10.17632/mz3n2gjjy3.1
Contributor:
John Frew

Description

Supplementary Material

Files

Categories

Atopic Dermatitis

Licence